Jingjing Zhang1, Bo Wang. 1. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China. xzmzjj@163.com
Abstract
OBJECTIVES: To study the role of arsenic trioxide (As(2)O(3)) in regulating peritoneal invasive activity of ovarian carcinoma cells in vitro and in vivo. METHODS: The effects of As(2)O(3) on human ovarian cancer cell lines (3AO, SW626 and HO-8910PM) migration, invasion and adhesion with tumor cells and human peritoneal mesothelial cells (HPMC) were observed by means of cell migration test, cell invasion test and cell adhesion test. The effects of As(2)O(3) on MMP-2, MMP-9, TIMP-1 and TIMP-2 gene expressions and protein expressions of tumor cells were determined by RT-PCR and ELISA, respectively. In animal experiments, ovarian tumor cells were implanted into abdominal cavity of nude mice and then the nude mice were treated by intraperitoneal injection of different doses As(2)O(3). The foci on the surface of peritoneum were counted. RESULTS: As(2)O(3) inhibited tumor cells migration, invasion and adhesion with HPMC in a dose-dependent manner, while the same treatment enhanced tumor cell-tumor cell interactions. As(2)O(3) inhibited mRNA and protein expressions of MMP-2, MMP-9 and TIMP-2 of tumor cells. In contrast, As(2)O(3) increased mRNA and protein expressions of TIMP-1. As(2)O(3) could reduce tumor cells peritoneal metastasis in nude mice. CONCLUSION: As(2)O(3) inhibits in vitro and in vivo peritoneal invasive activity of ovarian carcinoma cells in a dose-dependent manner. Its anti-invasive activity may be the results of reduced cell motility, inhibited attachment of tumor cells to HPMC and enhanced tumor cell-tumor cell interaction, as well as down-regulation of MMP-2 and MMP-9 levels and up-regulation of TIMP-1 level.
OBJECTIVES: To study the role of arsenic trioxide (As(2)O(3)) in regulating peritoneal invasive activity of ovarian carcinoma cells in vitro and in vivo. METHODS: The effects of As(2)O(3) on humanovarian cancer cell lines (3AO, SW626 and HO-8910PM) migration, invasion and adhesion with tumor cells and human peritoneal mesothelial cells (HPMC) were observed by means of cell migration test, cell invasion test and cell adhesion test. The effects of As(2)O(3) on MMP-2, MMP-9, TIMP-1 and TIMP-2 gene expressions and protein expressions of tumor cells were determined by RT-PCR and ELISA, respectively. In animal experiments, ovarian tumor cells were implanted into abdominal cavity of nude mice and then the nude mice were treated by intraperitoneal injection of different doses As(2)O(3). The foci on the surface of peritoneum were counted. RESULTS:As(2)O(3) inhibited tumor cells migration, invasion and adhesion with HPMC in a dose-dependent manner, while the same treatment enhanced tumor cell-tumor cell interactions. As(2)O(3) inhibited mRNA and protein expressions of MMP-2, MMP-9 and TIMP-2 of tumor cells. In contrast, As(2)O(3) increased mRNA and protein expressions of TIMP-1. As(2)O(3) could reduce tumor cells peritoneal metastasis in nude mice. CONCLUSION:As(2)O(3) inhibits in vitro and in vivo peritoneal invasive activity of ovarian carcinoma cells in a dose-dependent manner. Its anti-invasive activity may be the results of reduced cell motility, inhibited attachment of tumor cells to HPMC and enhanced tumor cell-tumor cell interaction, as well as down-regulation of MMP-2 and MMP-9 levels and up-regulation of TIMP-1 level.
Authors: Clarisse S Muenyi; Allan R Pinhas; Teresa W Fan; Guy N Brock; C William Helm; J Christopher States Journal: Toxicol Sci Date: 2012-02-13 Impact factor: 4.849
Authors: Richard W Ahn; Feng Chen; Haimei Chen; Stephan T Stern; Jeffrey D Clogston; Anil K Patri; Meera R Raja; Elden P Swindell; Vamsi Parimi; Vincent L Cryns; Thomas V O'Halloran Journal: Clin Cancer Res Date: 2010-06-02 Impact factor: 12.531
Authors: Colin E Olsen; Andrew E Liguori; Yue Zong; R Clark Lantz; Jefferey L Burgess; Scott Boitano Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-06-06 Impact factor: 5.464
Authors: Yilin Zhang; Hilary A Kenny; Elden P Swindell; Anirban K Mitra; Patrick L Hankins; Richard W Ahn; Katja Gwin; Andrew P Mazar; Thomas V O'Halloran; Ernst Lengyel Journal: Mol Cancer Ther Date: 2013-09-23 Impact factor: 6.261
Authors: Clarisse S Muenyi; Vanessa A States; Joshua H Masters; Teresa W Fan; C William Helm; J Christopher States Journal: J Ovarian Res Date: 2011-06-22 Impact factor: 4.234